Stockhub

Regeneus Ltd: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

25 September 2022

  • curprev 12:4812:48, 25 September 2022 >Nick 646 bytes +646 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. Its lead platform technology includes Progenza, a multi-synergistic therapy for the treatment of osteoarthritis and neuropathic pain. The company also develops Sygenus for the treat..."
Retrieved from "https://stockhub.co/research/Regeneus_Ltd"